© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 11, 2016
Specialty drug costs for 13 to 23 million patients in the United States would be $185 to 342 billion.
April 05, 2016
Model predicts millions of dollars can be saved just by avoiding 3 high-cost, low-reward drugs.
April 04, 2016
Are the unmeasured, potential benefits of indication-specific pricing worth the complication and risk?
Approval of first oral proteasome inhibitor, ixazomib (Ninlato), may ease treatment burden for multiple myeloma.